News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

By Jennifer K. Wagner, Genomics Law Report | 02.23.2016
Untitled Document

Chadam v. PAUSD, as previously covered on Genomics Law Report, is a case in which parents...

By Danielle Venton, KQED Science | 02.22.2016
Untitled Document

When you hear “gene editing,” do you think cancer cures? Designer babies? What about new fuel sources or drought-tolerant...

By Robert Gebelhoff, The Washington Post | 02.22.2016
Untitled Document

For a half-century, the ethics of human genetic engineering have been discussed in the abstract. Because the tools...

By Donald G. McNeil Jr., The New York Times | 02.22.2016
Untitled Document

As diagnostic tests rely on ever-tinier amounts of blood, some scientists are striking a note of caution. As...

By John Vibes, The Free Thought Project | 02.21.2016
Untitled Document

New York, NY – A group of scientists who worked at a crime lab for the New York...

By Adam S. Cohen, Harvard Magazine | 02.19.2016
Untitled Document

In August 1912, Harvard president emeritus Charles William Eliot addressed the Harvard Club of San Francisco on a...

By Sara Reardon, Nature News | 02.19.2016
Untitled Document

In July 2015, the major antibody provider Santa Cruz Biotechnology owned 2,471 rabbits and 3,202 goats. Now the...

By Alex Lash, Xconomy | 02.18.2016
Untitled Document

San Franisco — If you ask people who don’t follow biotech too closely what they know about CRISPR...